Mohan V, Seedat YK, Pradeepa R. The rising burden of diabetes and hypertension in southeast Asian and African regions: Need for effective strategies for prevention and control in primary health care settings. Int J Hypertens 2013; 2013: 409083.
Swami SS, Swami SC, Patil VW, Kanhere AM. Hypertension and diabetes in India: A review. Int J Clin Biochem Res 2015; 2: 54-8.
Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control: A systematic analysis of population-based studies from 90 countries. Circulation 2016; 134: 441-50.
World Health Organization. A global brief on hypertension. World Health Day 2013; pp. 1-39.
James PA, Oparil S, Carter BL, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults report from the panel members appointed to the eighth Joint National Committee (JNC 8). JAMA 2014; 311: 507-20.
Verdecchia P, Reboldi G, Angeli F, et al. Adverse prognostic significance of new diabetes in treated hypertensive subjects. Hypertension 2004; 43: 963-9.
Carter BL, Einhorn PT, Brands M, et al. Thiazide induced dysglycemia: Call for research from a working group from the national heart, lung, and blood institute. Hypertension 2008; 52: 30-6.
Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: A network meta-analysis. Lancet 2007; 369: 201-7.
Helgeland A, Leren P, Foss OP, Hjermann I, Holme I, Lund-Larsen PG. Serum glucose levels during long-term observation of treated and untreated men with mild hypertension. The Oslo study. Am J Med 1984; 76: 802-5.
Mykkanen L, Kuusisto J, Pyorala K, Laakso M, Haffner SM. Increased risk of non-insulin-dependent diabetes mellitus in elderly hypertensive subjects. J Hypertens 1994; 12: 1425-2.
Karagiannis A, Tziomalos K, Pagourelias ED, Gossios TD, Athyros VG. Effect of antihypertensive drug-associated diabetes on cardiovascular risk. Hellenic J Cardiol 2010; 51: 195-9.
Gurwitz JH, Bohn RL, Bohn RL, et al. Antihypertensive drug therapy and the initiation of treatment for diabetes mellitus. Ann Intern Med 1992; 118: 273-8.
Blackburn DF, Wilson TW. Antihypertensive medications and blood sugar: Theories and implications. Can J Cardiol 2006; 22: 229-3.
Dunder K, Lind L, Zethelius B, Berglund L, Lithell H. Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: Population based cohort study. BMJ 2003; 326: 681.
Hughes CA, Bennett V. Adducin: A physical model with implications for function in assembly of spectrin-actin complexes. J Biochem 1995; 270: 18990-6.
Ramu P, Umamaheswaran G, Shewade DG, Swaminathan RP, Balachander J, Adithan C. Gly460Trp polymorphism of the ADD1 gene and essential hypertension in an Indian population: A meta-analysis on hypertension risk. Indian J Hum Genet 2010; 16: 8-15.
Manunta P, Cusi D, Barlassina C, et al. Alpha-adducin polymorphisms and renal sodium handling in essential hypertensive patients. Kidney Int 1998; 53: 1471-8.
Gorden P. Glucose intolerance with hypokalemia: Failure of short-term potassium depletion in normal subjects to reproduce the glucose and insulin abnormalities of clinical hypokalemia. Diabetes 1973; 22: 544-51.
Zillich AJ, Garg J, Basu S, Bakris GL, Carter BL. Thiazide diuretics, potassium, and the development of diabetes: A quantitative review. Hypertension 2006; 48: 219-4.
Cusi D, Barlassina C, Azzani T, et al. Adducin polymorphism in primary hypertension: Linkage and association study; relationship to salt sensitivity. Lancet 1997; 349: 1353-7.
Cooper ME, Rumble JR, Allen TJ, O’brien RC, Jerums G, Doyle AE. Antihypertensive therapy in a model combining spontaneous hypertension with diabetes. Kidney Int 1992; 4: 898-3.
Bozkart O. Pharmacogenetics of antihypertensive drugs and risk
of diabetes. Thesis Utrecht University, chapter 2.1, page 19-31, 2007.
Gupta S, Chattopadhyaya I, Agrawal BK, Sehajpal PK, Goel RK. Correlation of Renin Angiotensin System (RAS) candidate gene polymorphisms with response to Ramipril in patients with essential hypertension. J Postgrad Med 2015; 61: 21-6.
Gupta S, Agrawal KB, Goel KR, Sehajpal KP. Angiotensin-converting enzyme gene polymorphism in hypertensive rural population of Haryana, India. J Emerg Trauma Shock 2009; 2: 150-4.
Miller SA, Dykes DD, Polesky HF. A simple salting procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
Shin MH, Chung EK, Kim HN, et al. Alphaadducin Gly460Trp polymorphism and essential hypertension in Korea. J Korean Med Sci 2004; 19: 812-4.
Gupta S, Agrawal BK, Sehajpal PK, Goel RK. Prevalence and predictors of essential hypertension in the rural population of haryana, India: An hospital based study. J Rural Trop Public Health 2011; 10: 29-4.
Gupta V, Singla R, Bedi M. Correlation of anthropometric parameters with blood pressure: an anthropometric study in North Indian Haryanvi males. Int J Anat Res 2016; 4: 2485-9.
Ranade K, Hsuing AC, Wu KD, et al. Lack of evidence for an association between alpha adducing and blood pressure regulation in Asian population. Am J Hyper 2000; 13: 704-9.
Manunta P, Burnier M, D’Amico M, et al. Adducin polymorphism affects renal proximal tubule reabsorption in hypertension. Hypertension 1999; 33: 694-7.
Ferrandi M, Salardi S, Tripodi G, et al. Evidence for an interaction between adducin and Na(+)-K(+)-ATPase: relation to genetic hypertension. Am J Physiol 1999; 277: H1338-9.
Plavinik FL, Rodrigues CIS, Zanella MT, Ribeiro AB. Hypokalemia, glucose intolerance, and hyperinsulinemia during diuretic therapy. Hypertension 1992; 19(Suppl. II): II-26-II-2.